Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Asselain

Showing results (91-100 of 227) with videos related to

Pageof 23
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 20, 2003
Neo adjuvant Tamoxifen in post menopausal patients with operable breast cancerR J Salmon, Y Remvikos, F Campana, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 13, 2015
Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?M Laé, A Lebel, F Hamel-Viard, et al.
Journal De Radiologie|May 1, 1995
[Diagnosis of non-palpable breast lesions: contribution of cytological punctures after stereotaxic localization]M Meunier, M Le Gal, J Klijanienko, et al.
Contemporary Clinical Trials|April 24, 2012
Dose-finding designs in pediatric phase I clinical trials: comparison by simulations in a realistic timeline frameworkA Doussau, B Asselain, M C Le Deley, et al.
Cancer|November 15, 1980
Chemotherapy--radiotherapy association in Hodgkin's disease, clinical stages IA, II2A: results of a prospective clinical trial with 166 patientsJ M Andrieu, B Montagnon, B Asselain, et al.
Deutsche Medizinische Wochenschrift (1946)|September 28, 1979
[Possibilities of radiation-dose reduction in the treatment of Hodgkin's disease. I. Exclusion of the mediastinum from the radiation field in primary high-cervical or infradiaphragmatic involvement and stage I or II (author's transl)]E Teillet, H Delbrück, C Bayle-Weisgerber, et al.
Acta Haematologica|January 1, 1981
Chemotherapy-radiotherapy versus chemotherapy in Hodgkin's disease with bone marrow involvement. Retrospective analysis of 32 casesJ M Andrieu, P Cramer, B Asselain, et al.
Bulletin Du Cancer|March 6, 1999
[Conservative treatment of multifocal breast cancer: a comparative study]C Nos, D Bourgeois, C Darles, et al.
Bulletin Du Cancer|January 1, 1982
[Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors]P Pouillart, H Madgelenat, M Jouve, et al.
Presse Medicale (Paris, France : 1983)|January 12, 1985
[Prevention of postoperative lymphocele after breast amputation]R J Salmon, H S Cody, J B Vedrenne, et al.
Pageof 23

Showing results (91-100 of 227) with videos related to

Sort By:
Pageof 23
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 20, 2003
Neo adjuvant Tamoxifen in post menopausal patients with operable breast cancerR J Salmon, Y Remvikos, F Campana, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 13, 2015
Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?M Laé, A Lebel, F Hamel-Viard, et al.
Journal De Radiologie|May 1, 1995
[Diagnosis of non-palpable breast lesions: contribution of cytological punctures after stereotaxic localization]M Meunier, M Le Gal, J Klijanienko, et al.
Contemporary Clinical Trials|April 24, 2012
Dose-finding designs in pediatric phase I clinical trials: comparison by simulations in a realistic timeline frameworkA Doussau, B Asselain, M C Le Deley, et al.
Cancer|November 15, 1980
Chemotherapy--radiotherapy association in Hodgkin's disease, clinical stages IA, II2A: results of a prospective clinical trial with 166 patientsJ M Andrieu, B Montagnon, B Asselain, et al.
Deutsche Medizinische Wochenschrift (1946)|September 28, 1979
[Possibilities of radiation-dose reduction in the treatment of Hodgkin's disease. I. Exclusion of the mediastinum from the radiation field in primary high-cervical or infradiaphragmatic involvement and stage I or II (author's transl)]E Teillet, H Delbrück, C Bayle-Weisgerber, et al.
Acta Haematologica|January 1, 1981
Chemotherapy-radiotherapy versus chemotherapy in Hodgkin's disease with bone marrow involvement. Retrospective analysis of 32 casesJ M Andrieu, P Cramer, B Asselain, et al.
Bulletin Du Cancer|March 6, 1999
[Conservative treatment of multifocal breast cancer: a comparative study]C Nos, D Bourgeois, C Darles, et al.
Bulletin Du Cancer|January 1, 1982
[Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors]P Pouillart, H Madgelenat, M Jouve, et al.
Presse Medicale (Paris, France : 1983)|January 12, 1985
[Prevention of postoperative lymphocele after breast amputation]R J Salmon, H S Cody, J B Vedrenne, et al.
Pageof 23